News | ECG | September 01, 2021

Noncontact ECG Monitoring a Step Closer for Neonatal Wards

Baby face detector software embedded in digital camera rivals ECG

A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.

A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.


September 1, 2021 — University of South Australia researchers have designed a computer vision system that can automatically detect a tiny baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as an electrocardiogram machine.

Using artificial intelligence-based software to detect human faces is now common with adults, but this is the first time that researchers have developed software to reliably detect a premature baby’s face and skin when covered in tubes, clothing, and undergoing phototherapy.

Engineering researchers and a neonatal critical care specialist from UniSA remotely monitored heart and respiratory rates of seven infants in the Neonatal Intensive Care Unit (NICU) at Flinders Medical Centre in Adelaide, using a digital camera.

“Babies in neonatal intensive care can be extra difficult for computers to recognize because their faces and bodies are obscured by tubes and other medical equipment,” said UniSA Professor Javaan Chahl, one of the lead researchers.

“Many premature babies are being treated with phototherapy for jaundice, so they are under bright blue lights, which also makes it challenging for computer vision systems.”

The "baby detector" was developed using a dataset of videos of babies in NICU to reliably detect their skin tone and faces.

Vital sign readings matched those of an electrocardiogram (ECG) and in some cases appeared to outperform the conventional electrodes, endorsing the value of non-contact monitoring of pre-term babies in intensive care.

The study is part of an ongoing UniSA project to replace contact-based electrical sensors with non-contact video cameras, avoiding skin tearing and potential infections that adhesive pads can cause to babies’ fragile skin.

Infants were filmed with high-resolution cameras at close range and vital physiological data extracted using advanced signal processing techniques that can detect subtle color changes from heartbeats and body movements not visible to the human eye.

UniSA neonatal critical care specialist Kim Gibson says using neural networks to detect the faces of babies is a significant breakthrough for non-contact monitoring.

“In the NICU setting it is very challenging to record clear videos of premature babies. There are many obstructions, and the lighting can also vary, so getting accurate results can be difficult. However, the detection model has performed beyond our expectations.

“Worldwide, more than 10 per cent of babies are born prematurely and due to their vulnerability, their vital signs need to be monitored continuously. Traditionally, this has been done with adhesive electrodes placed on the skin that can be problematic, and we believe non-contact monitoring is the way forward,” Gibson says.

Professor Chahl said the results are particularly relevant given the COVID-19 pandemic and need for physical distancing.

In 2020, the UniSA team developed world-first technology, now used in commercial products sold by North American company Draganfly, that measures adults’ vital signs to screen for symptoms of COVID-19.

The results have been published in the Journal of Imaging.

References: 

1. Fatema-Tuz-Zohra Khanam, Asanka G. Perera, Ali Al-Naji, et al. Non-Contact Automatic Vital Signs Monitoring of Infants in a Neonatal Intensive Care Unit Based on Neural Networks. J. Imaging 2021, 7(8), 122; https://doi.org/10.3390/jimaging7080122/. Published 23 July 2021.

 


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now